RenaissThera, VedTechBio’s Collaborator, Successfully Raises Seed Round to Advance its Pipeline in Obesity and Type II Diabetes

BENGALURU, India – June 26, 2026

Share

VedTechBio extends its congratulations to its collaboration partner RenaissThera on the successful raise of its seed round funding thus marking a significant milestone in advancing innovative therapeutics for Obesity and Diabetes.

VedTechBio has supported RenaissThera, leveraging its proprietary agentic AI platform, RxAgentAI and combining deep scientific expertise with seamless administrative support to accelerate progress in drug discovery and development. It looks forward to further strengthening this collaboration and driving meaningful outcomes in the next phase of growth.

VedTechBio remains committed to empowering ventures like RenaissThera by enhancing speed, precision, and impact across every stage of drug discovery and development

Learn more: www.vedtechbio.com